Single Nucleotide Polymorphisms in MCP-1 and Its Receptor Are Associated with the Risk of Age Related Macular Degeneration

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2012 Nov 28

PMID 23185481

Citations 40

Authors

Akshay Anand

Neel Kamal Sharma

Amod Gupta

Sudesh Prabhakar

Suresh Kumar Sharma

Ramandeep Singh

Pawan Kumar Gupta

Affiliations

Soon will be listed here.

Abstract

Background: Age-related macular degeneration (AMD) is the leading cause of blindness in the elderly population. We have shown previously that mice deficient in monocyte chemoattractant protein-1 (MCP1/CCL2) or its receptor (CCR2) develop the features of AMD in senescent mice, however, the human genetic evidence so far is contradictory. We hypothesized that any dysfunction in the CCL2 and its receptor result could be the contributing factor in pathogenesis of AMD.

Methods And Findings: 133 AMD patients and 80 healthy controls were enrolled for this study. Single neucleotid Polymorphism for CCL2 and CCR2 was analyzed by real time PCR. CCL2 levels were determined by enzyme-linked immunosorbent assay (ELISA) after normalization to total serum protein and percentage (%) of CCR2 expressing peripheral blood mononuclear cells (PBMCs) was evaluated using Flow Cytometry. The genotype and allele frequency for both CCL2 and CCR2 was found to be significantly different between AMD and normal controls. The CCL2 ELISA levels were significantly higher in AMD patients and flow Cytometry analysis revealed significantly reduced CCR2 expressing PBMCs in AMD patients as compared to normal controls.

Conclusions: We analyzed the association between single neucleotide polymorphisms (SNPs) of CCL2 (rs4586) and CCR2 (rs1799865) with their respective protein levels. Our results revealed that individuals possessing both SNPs are at a higher risk of development of AMD.

Citing Articles

Association of The rs1024611 Polymorphism with Polycystic Ovary Syndrome in A Population of Indian Women: A Case-Control Study.

Francis J, Sebastian H, Daniel S, Varghese L, Gilvaz S, Thenkattil Sankarankutty R Int J Fertil Steril. 2025; 19(1):44-49.

PMID: 39827390 PMC: 11744199. DOI: 10.22074/ijfs.2024.1974120.1406.

Sulfated CXCR3 Peptide Trap Use as a Promising Therapeutic Approach for Age-Related Macular Degeneration.

Jo G, Chae J, Jung S, Lyu J, Chung H, Lee J Biomedicines. 2024; 12(1).

PMID: 38275412 PMC: 10813770. DOI: 10.3390/biomedicines12010241.

Exploring the pathogenesis of age-related macular degeneration: A review of the interplay between retinal pigment epithelium dysfunction and the innate immune system.

Wong J, Ma J, Jobling A, Brandli A, Greferath U, Fletcher E Front Neurosci. 2022; 16:1009599.

PMID: 36408381 PMC: 9670140. DOI: 10.3389/fnins.2022.1009599.

, Gene Variants and CCL2, CCR2 Serum Levels Association with Age-Related Macular Degeneration.

Gudauskiene G, Vilkeviciute A, Gedvilaite G, Liutkeviciene R, Zaliuniene D Life (Basel). 2022; 12(7).

PMID: 35888126 PMC: 9322437. DOI: 10.3390/life12071038.

Integrative Approach to COVID-19: An Indian Facebook Recipe for Mental Health.

Anand A, Tyagi R, Khosla R, Bali P, Rain M, Maity K Ann Neurosci. 2022; 28(3-4):183-190.

PMID: 35341237 PMC: 8948334. DOI: 10.1177/09727531211052971.

References

Lommatzsch A, Hermans P, Muller K, Bornfeld N, Bird A, Pauleikhoff D . Are low inflammatory reactions involved in exudative age-related macular degeneration? Morphological and immunhistochemical analysis of AMD associated with basal deposits. Graefes Arch Clin Exp Ophthalmol. 2008; 246(6):803-10. DOI: 10.1007/s00417-007-0749-4. View

Simonelli F, Frisso G, Testa F, Fiore R, Vitale D, Manitto M . Polymorphism p.402Y>H in the complement factor H protein is a risk factor for age related macular degeneration in an Italian population. Br J Ophthalmol. 2006; 90(9):1142-5. PMC: 1857371. DOI: 10.1136/bjo.2006.096487. View

Ambati J, Anand A, Fernandez S, Sakurai E, Lynn B, Kuziel W . An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat Med. 2003; 9(11):1390-7. DOI: 10.1038/nm950. View

Jemaa R, Rojbani H, Kallel A, Ben Ali S, Feki M, Chabrak S . Association between the -2518G/A polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and myocardial infarction in Tunisian patients. Clin Chim Acta. 2008; 390(1-2):122-5. DOI: 10.1016/j.cca.2008.01.004. View

Charo I, Taubman M . Chemokines in the pathogenesis of vascular disease. Circ Res. 2004; 95(9):858-66. DOI: 10.1161/01.RES.0000146672.10582.17. View

Tuo J, Bojanowski C, Zhou M, Shen D, Ross R, Rosenberg K . Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration. Invest Ophthalmol Vis Sci. 2007; 48(8):3827-36. PMC: 2048751. DOI: 10.1167/iovs.07-0051. View

Charo I, Myers S, Herman A, Franci C, Connolly A, Coughlin S . Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc Natl Acad Sci U S A. 1994; 91(7):2752-6. PMC: 43448. DOI: 10.1073/pnas.91.7.2752. View

Chen M, Forrester J, Xu H . Dysregulation in retinal para-inflammation and age-related retinal degeneration in CCL2 or CCR2 deficient mice. PLoS One. 2011; 6(8):e22818. PMC: 3151263. DOI: 10.1371/journal.pone.0022818. View

Luhmann U, Robbie S, Munro P, Barker S, Duran Y, Luong V . The drusenlike phenotype in aging Ccl2-knockout mice is caused by an accelerated accumulation of swollen autofluorescent subretinal macrophages. Invest Ophthalmol Vis Sci. 2009; 50(12):5934-43. PMC: 2801148. DOI: 10.1167/iovs.09-3462. View

10.

Kaur I, Hussain A, Hussain N, Das T, Pathangay A, Mathai A . Analysis of CFH, TLR4, and APOE polymorphism in India suggests the Tyr402His variant of CFH to be a global marker for age-related macular degeneration. Invest Ophthalmol Vis Sci. 2006; 47(9):3729-35. DOI: 10.1167/iovs.05-1430. View

11.

Ormsby R, Ranganathan S, Tong J, Griggs K, Dimasi D, Hewitt A . Functional and structural implications of the complement factor H Y402H polymorphism associated with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008; 49(5):1763-70. DOI: 10.1167/iovs.07-1297. View

12.

Higgins G, Wang J, Dockery P, Cleary P, Redmond H . Induction of angiogenic cytokine expression in cultured RPE by ingestion of oxidized photoreceptor outer segments. Invest Ophthalmol Vis Sci. 2003; 44(4):1775-82. DOI: 10.1167/iovs.02-0742. View

13.

Scholl H, Charbel Issa P, Walier M, Janzer S, Pollok-Kopp B, Borncke F . Systemic complement activation in age-related macular degeneration. PLoS One. 2008; 3(7):e2593. PMC: 2440421. DOI: 10.1371/journal.pone.0002593. View

14.

Kim M, Wahl L, Yanek L, Becker D, Becker L . A monocyte chemoattractant protein-1 gene polymorphism is associated with occult ischemia in a high-risk asymptomatic population. Atherosclerosis. 2006; 193(2):366-72. DOI: 10.1016/j.atherosclerosis.2006.06.029. View

15.

Patel M, Chan C . Immunopathological aspects of age-related macular degeneration. Semin Immunopathol. 2008; 30(2):97-110. PMC: 2441602. DOI: 10.1007/s00281-008-0112-9. View

16.

Combadiere C, Potteaux S, Rodero M, Simon T, Pezard A, Esposito B . Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation. 2008; 117(13):1649-57. DOI: 10.1161/CIRCULATIONAHA.107.745091. View

17.

Haas P, Steindl K, Aggermann T, Schmid-Kubista K, Krugluger W, Hageman G . Serum VEGF and CFH in exudative age-related macular degeneration. Curr Eye Res. 2010; 36(2):143-8. PMC: 4853911. DOI: 10.3109/02713683.2010.533808. View

18.

Jonas J, Tao Y, Neumaier M, Findeisen P . Monocyte chemoattractant protein 1, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1 in exudative age-related macular degeneration. Arch Ophthalmol. 2010; 128(10):1281-6. DOI: 10.1001/archophthalmol.2010.227. View

19.

Raoul W, Auvynet C, Camelo S, Guillonneau X, Feumi C, Combadiere C . CCL2/CCR2 and CX3CL1/CX3CR1 chemokine axes and their possible involvement in age-related macular degeneration. J Neuroinflammation. 2010; 7:87. PMC: 3003653. DOI: 10.1186/1742-2094-7-87. View

20.

Luster A . Chemokines--chemotactic cytokines that mediate inflammation. N Engl J Med. 1998; 338(7):436-45. DOI: 10.1056/NEJM199802123380706. View